1. Home
  2. VATE vs CRBU Comparison

VATE vs CRBU Comparison

Compare VATE & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • CRBU
  • Stock Information
  • Founded
  • VATE 1994
  • CRBU 2011
  • Country
  • VATE United States
  • CRBU United States
  • Employees
  • VATE N/A
  • CRBU N/A
  • Industry
  • VATE Metal Fabrications
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • VATE Industrials
  • CRBU Health Care
  • Exchange
  • VATE Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • VATE 98.2M
  • CRBU 93.0M
  • IPO Year
  • VATE 1996
  • CRBU 2021
  • Fundamental
  • Price
  • VATE $5.25
  • CRBU $1.07
  • Analyst Decision
  • VATE
  • CRBU Strong Buy
  • Analyst Count
  • VATE 0
  • CRBU 4
  • Target Price
  • VATE N/A
  • CRBU $8.50
  • AVG Volume (30 Days)
  • VATE 45.1K
  • CRBU 943.1K
  • Earning Date
  • VATE 05-06-2025
  • CRBU 05-08-2025
  • Dividend Yield
  • VATE N/A
  • CRBU N/A
  • EPS Growth
  • VATE N/A
  • CRBU N/A
  • EPS
  • VATE N/A
  • CRBU N/A
  • Revenue
  • VATE $1,066,100,000.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • VATE N/A
  • CRBU N/A
  • Revenue Next Year
  • VATE N/A
  • CRBU $161.81
  • P/E Ratio
  • VATE N/A
  • CRBU N/A
  • Revenue Growth
  • VATE N/A
  • CRBU N/A
  • 52 Week Low
  • VATE $3.25
  • CRBU $0.66
  • 52 Week High
  • VATE $13.79
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • VATE 40.07
  • CRBU 57.50
  • Support Level
  • VATE $5.63
  • CRBU $0.98
  • Resistance Level
  • VATE $8.28
  • CRBU $1.21
  • Average True Range (ATR)
  • VATE 0.69
  • CRBU 0.10
  • MACD
  • VATE -0.05
  • CRBU 0.02
  • Stochastic Oscillator
  • VATE 0.00
  • CRBU 68.23

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: